Capacidade funcional e tratamento antineoplásico

Simple item page
dc.TypeRevistas/Boletinspt_BR
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva
dc.contributor.authorINCA
dc.contributor.authorInstituto Nacional de Câncer (Brasil)
dc.contributor.authorSistema Único de Saúde (Brasil)
dc.contributor.authorBrasil. Ministério da Saúde
dc.date.accessioned2021-10-14T15:43:18Z
dc.date.available2021-10-14T15:43:18Z
dc.date.issued2021-09
dc.description1 p.
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/4255
dc.language.isoPortuguêspt_BR
dc.publisherINCApt_BR
dc.relation.ispartofseriesAno V, n. 52.
dc.subjectNeoplasiaspt_BR
dc.subjectAntineoplásicospt_BR
dc.subjectNeoplasmspt_BR
dc.subjectAntineoplastic Agents
dc.titleCapacidade funcional e tratamento antineoplásicopt_BR

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Setembro_2021.pdf
Size:
487.77 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Informe SUS - ONCO 2021